Literature DB >> 21267512

Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction.

Pei Wang1, Feng-Jiao Yang, Hui Du, Yun-Feng Guan, Tian-Ying Xu, Xue-Wen Xu, Ding-Feng Su, Chao-Yu Miao.   

Abstract

Obesity is an important risk factor for cardiovascular disease, diabetes and certain cancers. The fat mass- and obesity-associated (FTO) gene is tightly associated with the pathophysiology of obesity, whereas the exact role of FTO remains poorly understood. Here, we investigated the alternations of FTO mRNA and protein expression in the peripheral metabolic tissues and the brain upon energy restriction (ER) and explored the involvement of the leptin signaling pathway in FTO regulation under ER status. ER decreased the FTO mRNA and protein expression in hypothalamus and brainstem but not in periphery. Using double-immunofluorescence staining, FTO was found to be colocalized with the leptin receptor long isoform (LepRb) in arcuate nucleus of hypothalamus and the nucleus of the solitary tract. In LepRb mutant db/db mice, the FTO downregulation in brain and body weight reduction induced by ER were completely abolished. The enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) induced by ER was also impaired in db/db mice. Moreover, leptin directly activated the STAT3 signaling pathway and downregulated FTO in in vitro arcuate nucleus of hypothalamus cultures and in vivo wild-type mice but not db/db mice. Thus, our results provide the first evidence that the LepRb-STAT3 signaling pathway is involved in the brain FTO downregulation during ER.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267512      PMCID: PMC3105135          DOI: 10.2119/molmed.2010.00134

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  48 in total

1.  Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.

Authors:  Steven J Greco; Sraboni Sarkar; Gemma Casadesus; Xiongwei Zhu; Mark A Smith; J Wesson Ashford; Jane M Johnston; Nikolaos Tezapsidis
Journal:  Neurosci Lett       Date:  2009-03-25       Impact factor: 3.046

2.  Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.

Authors:  Daniela Spano; Roberta Russo; Vittorio Di Maso; Natalia Rosso; Luigi M Terracciano; Massimo Roncalli; Luigi Tornillo; Mario Capasso; Claudio Tiribelli; Achille Iolascon
Journal:  Mol Med       Date:  2009-12-21       Impact factor: 6.354

3.  Inactivation of the Fto gene protects from obesity.

Authors:  Julia Fischer; Linda Koch; Christian Emmerling; Jeanette Vierkotten; Thomas Peters; Jens C Brüning; Ulrich Rüther
Journal:  Nature       Date:  2009-02-22       Impact factor: 49.962

4.  Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.

Authors:  Pei Wang; Tian-Ying Xu; Yun-Feng Guan; Ding-Feng Su; Guo-Rong Fan; Chao-Yu Miao
Journal:  Cardiovasc Res       Date:  2008-10-24       Impact factor: 10.787

5.  Leptin regulated calcium channels of neuropeptide Y and proopiomelanocortin neurons by activation of different signal pathways.

Authors:  J-H Wang; F Wang; M-J Yang; D-F Yu; W-N Wu; J Liu; L-Q Ma; F Cai; J-G Chen
Journal:  Neuroscience       Date:  2008-06-05       Impact factor: 3.590

Review 6.  Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging.

Authors:  José M Carrascosa; Manuel Ros; Antonio Andrés; Teresa Fernández-Agulló; Carmen Arribas
Journal:  Exp Gerontol       Date:  2008-05-20       Impact factor: 4.032

7.  FTO genotype and the weight loss benefits of moderate intensity exercise.

Authors:  Jonathan A Mitchell; Timothy S Church; Tuomo Rankinen; Conrad P Earnest; Xuemei Sui; Steven N Blair
Journal:  Obesity (Silver Spring)       Date:  2009-10-01       Impact factor: 5.002

8.  Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats.

Authors:  Yi-Chun Loraine Tung; Eduard Ayuso; Xiaoye Shan; Fatima Bosch; Stephen O'Rahilly; Anthony P Coll; Giles S H Yeo
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

9.  Obesity associated genetic variation in FTO is associated with diminished satiety.

Authors:  Jane Wardle; Susan Carnell; Claire M A Haworth; I Sadaf Farooqi; Stephen O'Rahilly; Robert Plomin
Journal:  J Clin Endocrinol Metab       Date:  2008-06-26       Impact factor: 5.958

Review 10.  Leptin receptor signaling and the regulation of mammalian physiology.

Authors:  E C Villanueva; M G Myers
Journal:  Int J Obes (Lond)       Date:  2008-12       Impact factor: 5.095

View more
  39 in total

Review 1.  FTO genotype and weight loss in diet and lifestyle interventions: a systematic review and meta-analysis.

Authors:  Lingwei Xiang; Hongyu Wu; An Pan; Bhakti Patel; Guangda Xiang; Lu Qi; Robert C Kaplan; Frank Hu; Judith Wylie-Rosett; Qibin Qi
Journal:  Am J Clin Nutr       Date:  2016-02-17       Impact factor: 7.045

2.  Functional genomic characterization of the FTO locus in African Americans.

Authors:  Richard Gill; George Stratigopoulos; Joseph H Lee; Rudolph L Leibel
Journal:  Physiol Genomics       Date:  2019-09-18       Impact factor: 3.107

3.  Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression.

Authors:  Zhi-Yong Li; Si-Li Zheng; Pei Wang; Tian-Ying Xu; Yun-Feng Guan; Yi-Jie Zhang; Chao-Yu Miao
Journal:  CNS Neurosci Ther       Date:  2014-01-07       Impact factor: 5.243

Review 4.  The 'Fat Mass and Obesity Related' (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance.

Authors:  John R Speakman
Journal:  Curr Obes Rep       Date:  2015-03

5.  Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.

Authors:  Qiang Lu; Gang Lv; Andre Kim; Jong-Myung Ha; Suhkman Kim
Journal:  Oncol Lett       Date:  2012-10-19       Impact factor: 2.967

6.  Hypomorphism for RPGRIP1L, a ciliary gene vicinal to the FTO locus, causes increased adiposity in mice.

Authors:  George Stratigopoulos; Jayne F Martin Carli; Diana R O'Day; Liheng Wang; Charles A Leduc; Patricia Lanzano; Wendy K Chung; Michael Rosenbaum; Dieter Egli; Daniel A Doherty; Rudolph L Leibel
Journal:  Cell Metab       Date:  2014-05-06       Impact factor: 27.287

7.  Hypomorphism of Fto and Rpgrip1l causes obesity in mice.

Authors:  George Stratigopoulos; Lisa Cole Burnett; Richard Rausch; Richard Gill; David Barth Penn; Alicja A Skowronski; Charles A LeDuc; Anthony J Lanzano; Pumin Zhang; Daniel R Storm; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-04-11       Impact factor: 14.808

8.  A link between FTO, ghrelin, and impaired brain food-cue responsivity.

Authors:  Efthimia Karra; Owen G O'Daly; Agharul I Choudhury; Ahmed Yousseif; Steven Millership; Marianne T Neary; William R Scott; Keval Chandarana; Sean Manning; Martin E Hess; Hiroshi Iwakura; Takashi Akamizu; Queensta Millet; Cigdem Gelegen; Megan E Drew; Sofia Rahman; Julian J Emmanuel; Steven C R Williams; Ulrich U Rüther; Jens C Brüning; Dominic J Withers; Fernando O Zelaya; Rachel L Batterham
Journal:  J Clin Invest       Date:  2013-07-15       Impact factor: 14.808

9.  Qidantongmai protects endothelial cells against hypoxia-induced damage through regulating the serum VEGF-a level.

Authors:  Bing Wang; Wen Wang; Feng Li; Zongren Wang; Jing Ma; Gang Zhao
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-12-29

10.  FTO is a transcriptional repressor to auto-regulate its own gene and potentially associated with homeostasis of body weight.

Authors:  Shu-Jing Liu; Hui-Ling Tang; Qian He; Ping Lu; Tao Fu; Xu-Ling Xu; Tao Su; Mei-Mei Gao; Shumin Duan; Yan Luo; Yue-Sheng Long
Journal:  J Mol Cell Biol       Date:  2019-02-01       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.